COMMENT
Neurochem
The name of the company was indistinct and this is the closest result in the data base. It is a biotech company focused on brain health. It acquired an AI company called Metro Mark. It is signing more and more deals with pharmaceutical companies for up-front and royalty payments.
biotechnology / pharmaceutical
SELL
Neurochem
He likes it, the only downside is that because the Japaneese market has risen 40% over the last year, it's a bit expensive right now. He suggests going to a different fund which is not so centered on the Japaneese market.
biotechnology / pharmaceutical
DON'T BUY
Neurochem
Looking at his relative performer chart, it's been an underperformer. Has negative money flow. In a very clear downtrend.
biotechnology / pharmaceutical
BUY
Neurochem
There has been a general selloff of biotech stocks. Still believe in this company.
biotechnology / pharmaceutical
DON'T BUY
Neurochem
Feels it's a little pricey at these levels given where they are in the development of their program. Have some interesting programs.
biotechnology / pharmaceutical
BUY
Neurochem
Has been moving sideways which, for a biotech, is not too bad. The company has good backing. Should see considerable upside.
biotechnology / pharmaceutical
PAST TOP PICK
Neurochem
(A top pick Sept 9/03. Up100 %.) Still likes. The market opportunity is so big, would still buy at this price.
biotechnology / pharmaceutical
PAST TOP PICK
Neurochem
(A top pick Sept 9/03. Up 58%.) As a potential treatment for Alzheimer's. Good technology. Has some US financing which will get US investors interested.
biotechnology / pharmaceutical
TOP PICK
Neurochem
Into phase 3 trial. All cashed up. Will start to be getting attention.
biotechnology / pharmaceutical
BUY
Neurochem
Has a very strong range of products.
biotechnology / pharmaceutical
HOLD
Neurochem
Has gone up quite well and may stay level for awhile.
biotechnology / pharmaceutical
TOP PICK
Neurochem
Likes the managemnt. Big financial support.
biotechnology / pharmaceutical
Showing 1 to 12 of 12 entries
  • «
  • 1
  • »

Neurochem(NRM-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Neurochem is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Neurochem(NRM-T) Frequently Asked Questions

What is Neurochem stock symbol?

Neurochem is a OTC stock, trading under the symbol NRM-T on the (). It is usually referred to as or NRM-T

Is Neurochem a buy or a sell?

In the last year, there was no coverage of Neurochem published on Stockchase.

Is Neurochem a good investment or a top pick?

Neurochem was recommended as a Top Pick by on . Read the latest stock experts ratings for Neurochem.

Why is Neurochem stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Neurochem worth watching?

In the last year 0 stock analysts on Stockchase covered Neurochem. The stock is worth watching.

What is Neurochem stock price?

On , Neurochem (NRM-T) stock closed at a price of $.